HYPR CIK: 1833769

Hyperfine, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
197
FY22:
129
FY23:
88.9
FY24:
53.7
FY25:
50.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.99
FY22:
5.39
FY23:
5.29
FY24:
5.19
FY25:
4.35
Total assets
Change from FY21 to FY25
millions USD
FY21:
202
FY22:
134
FY23:
94.2
FY24:
58.9
FY25:
55.3

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
15.7
FY22:
8.80
FY23:
8.77
FY24:
8.73
FY25:
11.7
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.51
FY22:
1.53
FY23:
1.03
FY24:
1.13
FY25:
2.53
(positive)
Change from FY21 to FY25
millions USD
FY21:
186
FY22:
124
FY23:
84.4
FY24:
49.0
FY25:
41.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
202
FY22:
134
FY23:
94.2
FY24:
58.9
FY25:
55.3

All amounts in millions USD Data source:SEC EDGAR